Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.92%
#2 Pons Pons +41.13%
#3 Starpower Starpower +30.70%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.85%
#5 TENDIES TENDIES +24.42%
#6 SkyAI SkyAI +20.29%
#7 Mubarak Mubarak +20.11%
#8 StonkBroker StonkBroker +19.99%
#9 Decred Decred +19.75%
#10 PondCoin PondCoin +17.51%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Pozycja w akcjach #29362
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Cena akcji
$0.365
Ostatnia synchronizacja: 2025-08-01
Kapitalizacja rynkowa
$21.54M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Elevation Oncology, Inc. (ELEV)

Kategoria

Healthcare
Historia stopy dywidendy dla Elevation Oncology, Inc. (ELEV)
Stopa dywidendy (TTM) dla Elevation Oncology, Inc. (symbol akcji: ELEV) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Elevation Oncology, Inc. (ELEV) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH